Emerging novel antifungal agents (Q28368416)

Evaluation of the echinocandin antifungal MK-0991 (L-743,872): efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis

inferred from page(s)

published in

Drug Discovery Today

0 references

volume

5

0 references

issue

1

0 references

page(s)

25-32

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901430-0

7 January 2021

In vitro activity of a new semisynthetic echinocandin, LY-303366, against systemic isolates of Candida species, Cryptococcus neoformans, Blastomyces dermatitidis, and Aspergillus species

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901430-0

7 January 2021

Corynecandin: a novel antifungal glycolipid from Coryneum modonium

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901430-0

7 January 2021

Mer-WF3010, a new member of the papulacandin family. I. Fermentation, isolation and characterization

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901430-0

7 January 2021

Fusacandins A and B; novel antifungal antibiotics of the papulacandin class from Fusarium sambucinum. I. Identity of the producing organism, fermentation and biological activity

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901430-0

7 January 2021

Arthrichitin. A New Cell Wall Active Metabolite from Arthrinium phaeospermum.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901430-0

7 January 2021

Cell wall active antifungal compounds produced by the marine fungus hypoxylon oceanicum LL-15G256. I. Taxonomy and fermentation.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901430-0

7 January 2021

Cell wall active antifungal compounds produced by the marine fungus Hypoxylon oceanicum LL-15G256. II. Isolation and structure determination

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901430-0

7 January 2021

Cell wall active antifungal compounds produced by the marine fungus Hypoxylon oceanicum LL-15G256. III. Biological properties of 15G256 gamma.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901430-0

7 January 2021

Translation elongation factor 3: a fungus-specific translation factor?

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901430-0

7 January 2021

[Isolation and decomposition of sordarin]

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901430-0

7 January 2021

Elongation factor 2 as a novel target for selective inhibition of fungal protein synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901430-0

7 January 2021

Sordarins: A new class of antifungals with selective inhibition of the protein synthesis elongation cycle in yeasts

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901430-0

7 January 2021

Isolation and Characterisation of an Antifungal Antibiotic (GR135402) with Protein Synthesis Inhibition.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901430-0

7 January 2021

BE-31405, a new antifungal antibiotic produced by Penicillium minioluteum. I. Description of producing organism, fermentation, isolation, physico-chemical and biological properties

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901430-0

7 January 2021

Mutations in ribosomal protein L10e confer resistance to the fungal-specific eukaryotic elongation factor 2 inhibitor sordarin.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901430-0

7 January 2021

Ribosomal P-protein stalk function is targeted by sordarin antifungals.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901430-0

7 January 2021

Cispentacin, a new antifungal antibiotic. I. Production, isolation, physico-chemical properties and structure

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901430-0

7 January 2021

FR109615, a new antifungal antibiotic from Streptomyces setonii. Taxonomy, fermentation, isolation, physico-chemical properties and biological activity.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901430-0

7 January 2021

Molecular mode of action of the antifungal beta-amino acid BAY 10-8888

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901430-0

7 January 2021

Anti-Candida activity of cispentacin: the active transport by amino acid permeases and possible mechanisms of action

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901430-0

7 January 2021

Synthesis and antifungal activity of FR109615 analogs

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901430-0

7 January 2021

Cispentacin, a new antifungal antibiotic. II. In vitro and in vivo antifungal activities

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901430-0

7 January 2021

Azoxybacilin, a novel antifungal agent produced by Bacillus cereus NR2991. Production, isolation and structure elucidation

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901430-0

7 January 2021

A new methionine antagonist that has antifungal activity: mode of action.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901430-0

7 January 2021

Antifungal azoxybacilin exhibits activity by inhibiting gene expression of sulfite reductase

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901430-0

7 January 2021

Synthesis and structure-activity relationships of a novel antifungal agent, azoxybacilin

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901430-0

7 January 2021

Sphingolipid synthesis as a target for antifungal drugs. Complementation of the inositol phosphorylceramide synthase defect in a mutant strain of Saccharomyces cerevisiae by the AUR1 gene

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901430-0

7 January 2021

Aureobasidins, new antifungal antibiotics. Taxonomy, fermentation, isolation, and properties.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901430-0

7 January 2021

Structure of aureobasidin A

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901430-0

7 January 2021

Relationship between structure and biological activity of novel R106 analogs

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901430-0

7 January 2021

Syntheses of antifungal aureobasidin A analogs with alkyl chains for structure-activity relationship

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901430-0

7 January 2021

Role of ABC transporters in aureobasidin A resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901430-0

7 January 2021

Aureobasidins as new inhibitors of P-glycoprotein in multidrug resistant tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901430-0

7 January 2021

Rustmicin, a new macrolide antibiotic active against wheat stem rust fungus

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901430-0

7 January 2021

Neorustmicin A, a new macrolide antibiotic active against wheat stem rust fungus

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901430-0

7 January 2021

Inhibition of fungal sphingolipid biosynthesis by rustmicin, galbonolide B and their new 21-hydroxy analogs

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901430-0

7 January 2021

Rustmicin, a potent antifungal agent, inhibits sphingolipid synthesis at inositol phosphoceramide synthase

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901430-0

7 January 2021

Khafrefungin, a novel inhibitor of sphingolipid synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901430-0

7 January 2021

UK-2A, B, C and D, novel antifungal antibiotics from Streptomyces sp. 517-02. I. Fermentation, isolation, and biological properties.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901430-0

7 January 2021

UK-2A, B, C and D, novel antifungal antibiotics from Streptomyces sp. 517-02. II. Structural elucidation

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901430-0

7 January 2021

UK-3A, a novel antifungal antibiotic from Streptomyces sp. 517-02: fermentation, isolation, structural elucidation and biological properties

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901430-0

7 January 2021

The mode of action of UK-2A and UK-3A, novel antifungal antibiotics from Streptomyces sp. 517-02

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901430-0

7 January 2021

UK-2A, B, C and D, novel antifungal antibiotics from Streptomyces sp. 517-02. IV. Comparative studies of UK-2A with antimycin A3 on cytotoxic activity and reactive oxygen species generation in LLC-PK1 cells

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.52.480

Identifiers

DOI

10.1016/S1359-6446(99)01430-0

0 references

Fatcat ID

release_kmctxv73ozbbzcvr4q474nex2e

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/kmctxv73ozbbzcvr4q474nex2e

24 November 2022